Literature DB >> 3350819

Characterization of 69- and 100-kDa forms of 2-5A-synthetase from interferon-treated human cells.

A G Hovanessian1, J Svab, I Marié, N Robert, S Chamaret, A G Laurent.   

Abstract

The existence of distinct 69- and 100-kDa forms of 2-5A-synthetase in addition to the smaller (40 and 46 kDa) forms has recently been established. Using specific monoclonal antibodies we investigated the induction, synthesis, and activity of 69- and 100-kDa 2',5'-oligoadenylate (2-5A) synthetases in interferon-treated human Daudi cells. Although induction of these synthetases is detectable in cells treated with as little as 1-5 units/ml of human alpha-interferon, higher concentrations are required for maximum synthesis of the 100 kDa than the 69-kDa protein. At 5 units/ml of interferon, enhanced synthesis of both proteins is detectable at 4 h with maximum synthesis occurring between 8 to 12 and 12 to 16 h for 69- and 100-kDa 2-5A-synthetases, respectively. At 24 h after addition of interferon, synthesis of these synthetases declines due to a decrease of active interferon in the culture medium. The synthesis of both synthetases is blocked by actinomycin D, and the half-life of these proteins is estimated to be 8 h. The activities of immunoaffinity purified 69- and 100-kDa synthetases are dependent on double-stranded (ds)RNA but show different requirements for optimum concentration of dsRNA and pH of the reaction. The apparent Km of 69- and 100-kDa synthetases for ATP is 1.7 X 10(-3) M and 3.6 X 10(-3) M, respectively. At optimum conditions for the activity of these enzymes, the pattern of 2',5'-linked oligoadenylates synthesized are different, the 69-kDa protein synthesizing higher oligomers than the 100-kDa species. Taken together, these results indicate that the 69- and 100-kDa 2-5A-synthetases are distinct proteins each with specific characteristics of induction and enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350819

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Possible involvement of (2'5')oligoadenylate synthetase activity in pre-mRNA splicing.

Authors:  J Sperling; J Chebath; H Arad-Dann; D Offen; P Spann; R Lehrer; D Goldblatt; B Jolles; R Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 2.  A scientific journey through the 2-5A/RNase L system.

Authors:  Robert H Silverman
Journal:  Cytokine Growth Factor Rev       Date:  2007-07-27       Impact factor: 7.638

Review 3.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

4.  The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.

Authors:  Mikkel Søes Ibsen; Hans Henrik Gad; Karthiga Thavachelvam; Thomas Boesen; Philippe Desprès; Rune Hartmann
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

5.  Differential modulating effects of retinoic acid on interferon antiviral activity.

Authors:  C K Ho; B R Ou; C Y Wang; H Y Chen; T Kuwata
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 6.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 7.  Sequence-non-specific effects of RNA interference triggers and microRNA regulators.

Authors:  Marta Olejniczak; Paulina Galka; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2009-10-20       Impact factor: 16.971

Review 8.  Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes.

Authors:  M Kumar; G G Carmichael
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

9.  Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.

Authors:  J M Pawlotsky; A G Hovanessian; F Roudot-Thoraval; N Robert; M Bouvier; G Babany; J Duval; D Dhumeaux
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

10.  Role of ribonuclease L in viral pathogen-associated molecular pattern/influenza virus and cigarette smoke-induced inflammation and remodeling.

Authors:  Yang Zhou; Min-Jong Kang; Babal Kant Jha; Robert H Silverman; Chun Geun Lee; Jack A Elias
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.